相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer epigenomics: beyond genomics
Juan Sandoval et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2012)
Genetic characterization of large parathyroid adenomas
Luqman Sulaiman et al.
ENDOCRINE-RELATED CANCER (2012)
Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors
Luqman Sulaiman et al.
PLOS ONE (2012)
The DNA Methylome of Benign and Malignant Parathyroid Tumors
Lee F. Starker et al.
GENES CHROMOSOMES & CANCER (2011)
β-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas
F. Cetani et al.
ENDOCRINE-RELATED CANCER (2010)
CDC73/HRPT2 CpG island hypermethylation and mutation of 5′-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors
Michael A. Hahn et al.
ENDOCRINE-RELATED CANCER (2010)
Epigenetic regulation of Wnt signaling pathway in urological cancer
Vera L. Costa et al.
EPIGENETICS (2010)
Frequent Promoter Hypermethylation of the APC and RASSF1A Tumour Suppressors in Parathyroid Tumours
C. Christofer Juhlin et al.
PLOS ONE (2010)
Changes in CpG Islands Promoter Methylation Patterns during Ductal Breast Carcinoma Progression
Mohammad Obaidul Hoque et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores
Rafael A. Irizarry et al.
NATURE GENETICS (2009)
Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast
Michael J. Hayes et al.
CLINICAL CANCER RESEARCH (2008)
Identification of novel DNA methylation markers in cervical cancer
Hung-Cheng Lai et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Aberrant methylation of the HRPT2 gene in parathyroid carcinoma
Kimberly M. Hewitt et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2007)
β-catenin signaling in biological control and cancer
Nancy Gavert et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma
E. Dahl et al.
ONCOGENE (2007)
Parafibromin immunoreactivity:: its use as an additional diagnostic marker for parathyroid tumor classification
C. C. Juhlin et al.
ENDOCRINE-RELATED CANCER (2007)
The many ways of Wnt in cancer
Paul Polakis
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Accumulation of nonphosphorylated β-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors
Peyman Bjorklund et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
Association of DNA methylation and epigenetic inactivation of RASSF1A and beta-catenin with metastasis in small bowel carcinoid tumors
He-Yu Zhang et al.
ENDOCRINE (2006)
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J. Veeck et al.
ONCOGENE (2006)
Loss of parafibromin expression in a subset of parathyroid adenomas
C. Juhlin et al.
ENDOCRINE-RELATED CANCER (2006)
Promoter methylation of p16INK4, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma
J Li et al.
CANCER (2005)
Gland size is associated with changes in gene expression profiles in sporadic parathyrold adenomas
JE Rosen et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Role of the ras-association domain family 1 tumor suppressor gene in human cancers
A Agathanggelou et al.
CANCER RESEARCH (2005)
p16INK4a promoter methylation and protein expression in breast fibroadenoma and carcinoma
A Di Vinci et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
H Suzuki et al.
NATURE GENETICS (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma
TM Shattuck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
CpG island methylation in carcinoid and pancreatic endocrine tumors
AOO Chan et al.
ONCOGENE (2003)
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome
JD Carpten et al.
NATURE GENETICS (2002)
Methylation of the RASSF1A gene in human cancers
GP Pfeifer et al.
BIOLOGICAL CHEMISTRY (2002)
Epigenetic inactivation of RASSF14 in lung and breast cancers and malignant phenotype suppression
DG Burbee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
A Agathanggelou et al.
ONCOGENE (2001)
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
R Dammann et al.
NATURE GENETICS (2000)
Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism
T Carling et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor
T Carling et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
DNA hypermethylation in tumorigenesis - epigenetics joins genetics
SB Baylin et al.
TRENDS IN GENETICS (2000)
分享论文
